Please login to the form below

KemPharm

This page shows the latest KemPharm news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs Pfizer and Teva abuse-resistant painkillers

Last month the same panel also rejected an abuse-deterrent claim for KemPharm's Apadaz (benzhydrocodone hydrochloride and acetaminophen) whilst backing approval of the drug.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Senior Account Manager: Negotiable

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Senior Account Director development role to Business Director, H...: Excellent package

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Systematic Review Analyst - Oxford: Negotiable

Production Manager – Healthcare Communications: DOE

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Account Director: Excellent benefits

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Senior Medical Writer: Competitive Salary

Associate Editorial Director – Med Comms – London: Salary TBC

Consumer Health Account Director: Circa £60, 000 Gym and More

Senior Account Executive, London, Medical Communications: Excellent package

Medical Writers: Competitive Salary and Benefits

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Medical Writers Required – Cheshire: DOE

Project / Account Manager (Medical Education): Salary TBC

Scientific Director / Editorial Team Leader: Great salary and benefits

Associate Medical Director: Highly Competitive

Consultant Health Economics - London / Oxford: Negotiable

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Director, Market Access / HEOR - North-West: Negotiable

Medical/ Scientific Director: Salary TBC

Events Manager – Med Comms – Surrey: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Innovation in merger control and the impact on the pharmaceutical sector: Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think: Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Quality in Care Diabetes 2018: the best in innovative diabetes care: Awards highlight new evidence-based approaches to improving care...